Dynamic Management and Risk Control Under Medical Device Registration Regulations
In the supply chain management of the medical device industry, contract signing merely marks the starting point of cooperation, while dynamic management throughout the entire production cycle serves as the core guarantee for sustained compliance and consistent product safety and effectiveness. With the continuous improvement of China’s medical device regulatory system, procurement coordination is no longer a simple commercial performance activity, but is deeply integrated into the regulatory framework of national medical device registration application and full lifecycle supervision.
Regulatory Foundation and Classification Management of Medical Device Registration
China’s medical device supervision has undergone profound transformation from departmental administration to standardized legal management. In 2000, the State Council promulgated the Regulations on the Supervision and Administration of Medical Devices, officially launching the legalized supervision of medical devices in China. After multiple revisions, especially the implementation of the newly revised Regulations in 2021, the legislative purpose has achieved a fundamental shift from simply strengthening supervision to balancing safety guarantee and industrial development.
In procurement coordination and supplier management, the primary prerequisite is a thorough understanding of China’s medical device classification management system. Medical devices in China are divided into three risk-based classes: Class I devices are subject to product filing management, while Class II and Class III devices are under strict registration administration. Domestic Class II devices are reviewed and approved by provincial drug administration authorities, and domestic Class III devices as well as imported medical devices are regulated by the National Medical Products Administration. This means that during supplier screening and production coordination, enterprises must strictly verify suppliers’ valid Medical Device Registration Certificates or filing documents, ensure full alignment between product classification and approval authority, and prohibit the procurement of unregistered medical device products.
Remodeled Supply Chain Collaboration Under the Marketing Authorization Holder System
The fully implemented medical device Marketing Authorization Holder (MAH) system constitutes the core regulatory background that reshapes the logic of procurement coordination. The system empowers medical device marketing authorization holders to bear the primary legal responsibility for the full lifecycle quality and safety of registered products, and allows holders to conduct independent production or entrust qualified manufacturers for commissioned production, realizing the separation of product registration qualification and production licensing.
The MAH system has greatly expanded the dimension of procurement coordination. As the marketing authorization holder, enterprises retain full accountability for product safety, effectiveness and quality controllability even when production is entrusted to third-party suppliers. Therefore, procurement coordination covers far more than material delivery supervision; it extends to the extended quality system management of commissioned manufacturers. Holders must ensure commissioned manufacturers possess qualified production scope and quality assurance capabilities, and clearly define the rights, obligations and responsibility boundaries of both parties in quality control, adverse event monitoring and other compliance matters through procurement agreements.
Dynamic Compliance Management During Production Processes
Based on clarified regulatory frameworks and primary subject responsibilities, dynamic production management must strictly comply with the technical requirements and quality system standards submitted during product registration:
Progress visualization aligned with registration nodes
A regular production progress reporting mechanism is established to enable real-time monitoring of all production nodes, from material feeding and intermediate inspection to finished product release. Such visualization not only ensures on-time delivery, but also aligns production arrangements with the progress requirements of regulatory registration testing and clinical evaluations. Delays in key material supply or production suspension may compromise the batch representativeness of type testing results, thereby delaying the overall registration application or registration renewal process.
Strict change control management
Change control represents the most easily overlooked yet critical compliance risk point in medical device procurement and production management. In accordance with the Measures for the Administration of Medical Device Registration and Filing, any major changes to the technical requirements, production processes, raw materials or production sites of registered medical devices require prior registration modification or filing with the original regulatory authority. Accordingly, a rigorous change notification system must be enforced in procurement coordination. Suppliers shall obtain written approval and regulatory compliance assessment from the marketing authorization holder before implementing any changes to personnel, equipment, processes or production sites. Unauthorized arbitrary changes will result in severe legal risks, including the revocation of product registration certificates.
Deviation handling and quality traceability
In the event of production abnormalities, the procurement party shall intervene promptly, assist suppliers in conducting root cause analysis, and scientifically evaluate the impact of deviations on product quality and registered technical specifications. Under regulatory requirements, all deviation handling activities must be fully documented and incorporated into the quality management system. Preventing non-conforming products from entering the market is not only a basic commercial principle, but also a statutory obligation stipulated in the Regulations on the Supervision and Administration of Medical Devices to protect human health and life safety.
In summary, modern medical device procurement coordination is a highly specialized compliance management practice. Only by fully integrating regulatory requirements including the Regulations on the Supervision and Administration of Medical Devices, risk-based classification registration system and MAH system into the dynamic management and risk control of the supply chain can enterprises ensure efficient supply while building a solid compliance barrier for the safety and effectiveness of medical devices.
